logo

FDA Calendar

Share
Company Name Amarin Corp Plc
Drug Name Vascepa (sNDA)
Event Name FDA decision on Vascepa to reduce residual cardiovascular risk in patients with statin-managed LDL-C cholesterol
Event Date 09/28/2019
Outcome Date
Outcome
Drug Status Priority Review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar